We are live on !
Find out more
First Quadrant Portfolio holdings
AUM
$18M
Turnover
89.22%
1-Year Est. Return
24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.39%
10 Year Est. Return
–
AUM
$4.49B
AUM Growth
+$87.2M
(+2%)
Cap. Flow
-$70.7M
Cap. Flow % of AUM
Cap. Flow %
-1.57%
Top 10 Holdings %
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54
Avg Time Held
0.8
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$26.9M |
| 2 |
Elevance Health
ELV
|
+$26.5M |
| 3 |
Gilead Sciences
GILD
|
+$20M |
| 4 |
Zebra Technologies
ZBRA
|
+$18.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$27.8M |
| 2 |
Packaging Corp of America
PKG
|
+$25.4M |
| 3 |
Amgen
AMGN
|
+$21.4M |
| 4 |
Hershey
HSY
|
+$20.5M |
| 5 |
Edison International
EIX
|
+$19.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.39% |
| 2 | Technology | 15.39% |
| 3 | Healthcare | 14.54% |
| 4 | Industrials | 13.38% |
| 5 | Energy | 11.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.03T
| $103M | 2.29% |
4,422,292
+73,528
| +2% | +$1.56M |
2013 Q2
4 quarters
|
|
2
ExxonMobil
XOM
$764B
| $100M | 2.22% |
989,928
-42,500
| -4% | -$4.29M |
2013 Q2
4 quarters
|
|
3
Alphabet (Google) Class C
GOOG
$3.42T
| $77.1M | 1.72% |
2,666,762
-147,668
| -5% | -$4.01M |
2013 Q2
4 quarters
|
|
|
4
Johnson & Johnson
JNJ
$658B
| $73.4M | 1.63% |
702,029
+178,100
| +34% | +$18M |
2013 Q2
4 quarters
|
|
5
Microsoft
MSFT
$3.88T
| $66.8M | 1.49% |
1,601,879
-245,000
| -13% | -$9.9M |
2013 Q2
4 quarters
|
|
6
Berkshire Hathaway Class B
BRK.B
$1.16T
| $65.4M | 1.46% |
516,867
+3,800
| +0.7% | +$481K |
2013 Q2
4 quarters
|
|
7
SLB Ltd
SLB
$79.3B
| $62.1M | 1.38% |
526,814
-2,900
| -0.5% | -$299K |
2013 Q2
4 quarters
|
|
8
Oracle
ORCL
$396B
| $58.5M | 1.3% |
1,443,943
-45,500
| -3% | -$1.87M |
2013 Q2
4 quarters
|
|
9
Pfizer
PFE
$174B
| $57.2M | 1.27% |
2,032,139
+81,052
| +4% | +$2.31M |
2013 Q2
4 quarters
|
|
10
Union Pacific
UNP
$181B
| $56.6M | 1.26% |
567,560
-5,200
| -0.9% | -$504K |
2013 Q2
4 quarters
|
|
11
Bank of America
BAC
$346B
| $55.7M | 1.24% |
3,624,492
-9,100
| -0.3% | -$141K |
2013 Q2
4 quarters
|
|
12
Wells Fargo
WFC
$250B
| $52.5M | 1.17% |
998,436
+15,300
| +2% | +$769K |
2013 Q2
4 quarters
|
|
13
ConocoPhillips
COP
$185B
| $50M | 1.11% |
583,394
+223,279
| +62% | +$17.4M |
2013 Q2
4 quarters
|
|
14
JPMorgan Chase
JPM
$895B
| $49.6M | 1.1% |
860,770
-131,695
| -13% | -$7.4M |
2013 Q2
4 quarters
|
|
15
Qualcomm
QCOM
$176B
| $48.9M | 1.09% |
617,518
| – | – |
2013 Q2
4 quarters
|
|
16
AT&T
T
$144B
| $45.5M | 1.01% |
1,704,409
+7,167
| +0.4% | +$192K |
2013 Q2
4 quarters
|
|
17
CVS Health
CVS
$115B
| $44.6M | 0.99% |
591,412
-300
| -0.1% | -$22.7K |
2013 Q2
4 quarters
|
|
18
Comcast
CMCSA
$82.5B
| $42.3M | 0.94% |
1,577,532
+11,400
| +0.7% | +$293K |
2013 Q2
4 quarters
|
|
19
Occidental Petroleum
OXY
$64B
| $41M | 0.91% |
417,377
| – | – |
2013 Q2
4 quarters
|
|
|
20
Merck
MRK
$369B
| $40.5M | 0.9% |
734,255
+493,398
| +205% | +$26.9M |
2013 Q2
4 quarters
|
|
21
Chevron
CVX
$459B
| $38.7M | 0.86% |
296,521
-40,100
| -12% | -$4.99M |
2013 Q2
4 quarters
|
|
22
Verizon
VZ
$185B
| $37.6M | 0.84% |
769,331
-403,606
| -34% | -$19.6M |
2013 Q2
4 quarters
|
|
|
23
Gilead Sciences
GILD
$212B
| $37.6M | 0.84% |
453,873
+257,262
| +131% | +$20M |
2013 Q2
4 quarters
|
|
24
Home Depot
HD
$328B
| $37.6M | 0.84% |
464,500
| – | – |
2013 Q2
4 quarters
|
|
25
Medtronic
MDT
$123B
| $37.5M | 0.83% |
587,492
| – | – |
2013 Q2
4 quarters
|
|
Similar funds
ICMH
First Quadrant's Q2 2014 Portfolio in Review
As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
- First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
- First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
- First Quadrant fully exited BALLY TECHNOLOGIES, INC. in Q2 2014, selling an estimated $14.7M.
- First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
- First Quadrant opened 109 new positions and closed 54 in Q2 2014.
- First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.
Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.